Values as of: 2025-04-08
COMMON STOCK | Medical Instruments & Supplies |
Last Closing
USD 18.57Change
-0.56 (-2.93)%Market Cap
USD 5.88BVolume
0.44MVerdict
Verdict
Currency: USD
Country : USA
| Symbol | Name | Price(Change) | Market Cap |
|---|---|---|---|
| BDX | Becton Dickinson and Company |
-1.64 (-0.81%) |
USD 57.94B |
| ALC | Alcon AG |
+0.63 (+0.69%) |
USD 44.32B |
| RMD | ResMed Inc |
-2.48 (-1.16%) |
USD 31.43B |
| BAX | Baxter International Inc |
+0.02 (+0.07%) |
USD 14.28B |
| SOLV | Solventum Corp. |
-0.26 (-0.39%) |
USD 11.45B |
| AVTR | Avantor Inc |
-0.15 (-0.97%) |
USD 10.37B |
| ATR | AptarGroup Inc |
+1.06 (+0.74%) |
USD 9.51B |
| TFX | Teleflex Incorporated |
-0.30 (-0.23%) |
USD 6.39B |
| BLCO | Bausch + Lomb Corp |
-0.08 (-0.67%) |
USD 4.29B |
| WRBY | Warby Parker Inc |
-0.52 (-3.52%) |
USD 1.79B |
| Symbol | Name | Weight | Mer | Price(Change) | Market Cap |
|---|---|---|---|---|---|
| CIC:CA | CI Canadian Banks Covered.. | 15.16 % | 0.84 % |
-0.01 (0.73%) |
N/A |
| ZEB:CA | BMO S&P/TSX Equal Weight .. | 14.96 % | 0.60 % |
-0.02 (0.73%) |
CAD 4.06B |
| BNC:CA | Purpose Canadian Financia.. | 11.84 % | 0.68 % |
-0.17 (0.73%) |
N/A |
| ZWB:CA | BMO Covered Call Canadian.. | 10.83 % | 0.71 % |
-0.03 (0.73%) |
CAD 3.02B |
| CEW:CA | iShares Equal Weight Banc.. | 9.35 % | 0.60 % |
-0.15 (0.73%) |
CAD 0.24B |
| HEF:CA | 7.74 % | 0.83 % |
N/A |
N/A | |
| HCB:CA | 6.95 % | 0.65 % |
N/A |
N/A | |
| BFIN-U:CA | 5.72 % | 0.00 % |
N/A |
N/A | |
| XDV:CA | iShares Canadian Select D.. | 5.49 % | 0.55 % |
-0.04 (0.73%) |
CAD 1.71B |
| QXM:CA | First Asset Morningstar N.. | 5.32 % | 0.58 % |
+0.11 (+0.73%) |
CAD 0.08B |
| FIE:CA | iShares Canadian Financia.. | 4.95 % | 0.97 % |
-0.02 (0.73%) |
CAD 1.08B |
| NDIV:CA | NBI Canadian Dividend Inc.. | 4.55 % | 0.00 % |
N/A |
CAD 0.02B |
| PDC:CA | Invesco Canadian Dividend.. | 4.00 % | 0.55 % |
+0.04 (+0.73%) |
CAD 0.79B |
| XFN:CA | iShares S&P/TSX Capped Fi.. | 3.90 % | 0.61 % |
-0.16 (0.73%) |
CAD 1.70B |
| MCLC:CA | Manulife Multifactor Cana.. | 3.10 % | 0.45 % |
+0.06 (+0.73%) |
CAD 0.33B |
| FBE:CA | 2.65 % | 0.83 % |
N/A |
N/A | |
| BANK:CA | Evolve Canadian Banks and.. | 0.00 % | 0.39 % |
-0.01 (0.73%) |
CAD 0.40B |
| DXIF:CA | Dynamic Active Internatio.. | 0.00 % | 0.00 % |
+0.17 (+0.73%) |
CAD 6.86M |
| Market Performance vs. Industry/Classification (Medical Instruments & Supplies) | Market Performance vs. Exchange | ||||||
| Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
| YTD | |||||||
| Capital Gain | -14.78% | 58% | F | 35% | F | ||
| Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
| Total Return | -14.78% | 58% | F | 34% | F | ||
| Trailing 12 Months | |||||||
| Capital Gain | -36.69% | 37% | F | 13% | F | ||
| Dividend Return | 0.20% | 11% | F | 2% | F | ||
| Total Return | -36.49% | 37% | F | 12% | F | ||
| Trailing 5 Years | |||||||
| Capital Gain | N/A | N/A | N/A | N/A | N/A | ||
| Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
| Total Return | N/A | N/A | N/A | N/A | N/A | ||
| Average Annual (5 Year Horizon) | |||||||
| Capital Gain | 9.16% | 83% | B | 65% | D | ||
| Dividend Return | 9.18% | 83% | B | 58% | F | ||
| Total Return | 0.02% | 11% | F | 2% | F | ||
| Risk Return Profile | |||||||
| Volatility (Standard Deviation) | 42.34% | 39% | F | 21% | F | ||
| Risk Adjusted Return | 21.68% | 78% | C+ | 38% | F | ||
| Market Capitalization | 5.88B | 47% | F | 80% | B- | ||
| Target Price Action | Rating Action | Analyst | Rating | Price | Date |
|---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
The company had positive total cash flow in the most recent four quarters.
The company had positive total free cash flow in the most recent four quarters.
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
The stock is trading high compared to its peers median on a price to book value basis.
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
The company has under performed its peers on annual average total returns in the past 5 years.
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
